[1]
Upadhya D, Shetty AK. Extracellular vesicles as therapeutics for brain injury and disease. Curr Phar Des 2019; 25(33): 3500-5.
[2]
Kabir MT, Sufian MA, Uddin MS, et al. NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer’s therapy. Curr Phar Des 2019; 25(33): 3506-18.
Current Pharmaceutical Design
Title:New Drug Treatment Paradigms for Metabolic and Neurological Disorders
Volume: 25 Issue: 33
Author(s): Senthilkumar Sivanesan
Affiliation:
Export Options
About this article
Cite this article as:
Sivanesan Senthilkumar , New Drug Treatment Paradigms for Metabolic and Neurological Disorders, Current Pharmaceutical Design 2019; 25 (33) . https://dx.doi.org/10.2174/138161282533191119145548
DOI https://dx.doi.org/10.2174/138161282533191119145548 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
26
4
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements